The latest
report Global
Cancer Biomarkers Market, By Tumor (Breast, Lung, Prostate), By Type
(Protein Biomarker, Genetic Biomarkers), By Profiling Technology (Proteomics,
Genomics, Imaging, Immunoassay), By Application (Diagnostic, Drug Discovery,
Prognostic), By Geography (North America, Europe, Asia-Pacific, South America,
Rest of the World) – Industry Trends and Forecast to 2024
Report on the Global
Cancer Biomarkers Market 2017 gives the complete description of the market
across the globe. The contents that are provided in the report are briefly
discussed below.
Global
Cancer Biomarkers Market has accounted to USD 10.9 billion in 2016, growing at
a CAGR of 12.2% from 2017 to 2024, and is expected to reach USD 27.4 billion by
2024.
Request for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-biomarkers-market
Report Definition:
Cancer
biomarkers are the molecules secreted by a tumor or a specific response of the
human body indicating the presence of cancer. The biomarkers enable cancer
detection at an early stage and facilitate high-speed noninvasive diagnosis
using various genomics and proteomics tools. Cancer biomarkers are used for
various applications such as cancer diagnostics, drug discovery and
development, prognostics, personalized medicine, and surrogate endpoints. Over
the years, cancer biomarkers have become an integral part of research in
pharmaceutical and clinical trial companies, as they help to reduce the time
and cost of the drug discovery and development process.
Major Factors of Global Cancer
Biomarkers Market:
Factors
such as rising prevalence of cancer, increasing government support for cancer
biomarkers research, rising aging population, increasing use of biomarkers in
the drug discovery and development process, and increasing use of biomarker
tests for diagnosis purposes are fueling the growth of this market. However,
poorly suited regulatory and reimbursement systems and high capital investments
required for biomarker development and validation are the major factors
restraining the growth of this market. Cancer biomarkers’ research and
development is highly capital intensive; this is one of the key entry barriers for
new players willing to enter the cancer biomarkers market. Majority of the
biomarker development studies receive funding from government organizations or
large pharmaceutical companies.
For
Any Query Speak to Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-cancer-biomarkers-market
Report Segmentation:
In this report, the cancer biomarkers
market is segmented on the basis of type, cancer type, profiling technology,
application, and geography.
Based
on type, the cancer
biomarkers market is broadly
split into three segments, namely, protein biomarkers, genetic biomarkers, and
other biomarkers (includes viral, cell, and carbohydrate biomarkers). In 2015,
the protein biomarkers segment accounted for the largest share of the global
cancer biomarkers market. The large share of this segment is mainly attributed
to the tremendous potential of protein biomarkers in cancer detection,
diagnostics, prognostics, and clinical & therapeutic applications; and low
cost of the protein biomarker tests as compared to genetic biomarker tests. The
increasing focus of pharmaceutical companies towards the discovery of protein
biomarkers is further expected to fuel the growth of this market in the coming
years.
Based
on cancer type, the cancer
biomarkers market is categorized into breast cancer, lung cancer, colorectal
cancer, prostate cancer, cervical cancer, and other cancers (includes melanoma,
leukemia, gastric, kidney, liver, and pancreatic cancers).
The
cancer
biomarkers market, by profiling technology, is segmented
into omics technologies, imaging technologies, immunoassays, cytogenetics, and
bioinformatics. The omics technologies segment accounted for the largest share
of the global cancer biomarkers market in 2015. The largest share of this
segment is mainly attributed to the increased adoption of advanced high
throughput technologies in biomarker discovery and development and increasing
use of omics-based tests for cancer diagnosis and drug development process.
Omics technologies also represent the fastest-growing cancer biomarkers
segment. The high growth rate of this segment can be attributed to the
increasing adoption of advanced omics technologies for cancer detection and
drug discovery & development applications, specifically in developing
countries. Advances in high-throughput omics technologies are also contributing
to the growth of this market, by increasing the space of prospective biomarkers
in cancer research.
Read more about the Global Cancer Biomarkers
Market Report Visit @ http://databridgemarketresearch.com/reports/global-cancer-biomarkers-market/
Based on geography the global cancer biomarkers market is segmented into 5
geographical regions, North America, Europe, Asia-Pacific, South America and
rest of the world. The geographical regions are further segmented into 24 major
countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium,
Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia,
South Africa and many others.
Competitive
Landscape:
Some of the major players operating in
the global
cancer biomarkers market are Abbott Laboratories,
DiagnoCure Inc., Affymetrix, Inc., Illumina, Inc., Qiagen N.V., Roche
Diagnostics Ltd., Agilent Technologies Inc., Quest Diagnostics Inc., Merck
& Co. Inc., Hologic, Inc., and Becton Dickinson and Company among others.
Related
Report
Global
Radiopharmaceuticals Market – Industry Trends and Forecast to 2024
Global
Radiopharmaceuticals Market, By Type (Diagnostic, Therapeutic), Procedural
Volumes (Diagnostic Procedures, Therapeutic Procedures), Application, Sources
(Nuclear Reactors, Cyclotrons), End User, Geography (North America, Europe,
APAC, South America, MEA)– Industry Trends andForecast To 2024
Report Access: http://databridgemarketresearch.com/reports/pharmaceutical/global-radiopharmaceuticals-market-trends-forecast-2024/
About Data Bridge Market
Research:
Data Bridge
Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Contact:
Vishal
Dixit
Data
Bridge Market Research
Tel:
+1-888-387-2818
